SUTRO BIOPHARMA INC (STRO) Stock Analyst Ratings
NASDAQ:STRO - Nasdaq - US8693671021 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 73% to STRO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.34. This target is 336.38% above the current price.
STRO was analyzed by 17 analysts. The buy percentage consensus is at 73. So analysts seem to be have mildly positive about STRO.
In the previous month the buy percentage consensus was at a similar level.
STRO was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-04-29 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-03-17 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-03-14 | Citizens Capital Markets | Downgrade | Market Outperform -> Market Perform |
| 2025-03-14 | Wedbush | Downgrade | Outperform -> Neutral |
| 2025-03-14 | B of A Securities | Downgrade | Buy -> Underperform |
| 2024-12-11 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-12-11 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-11-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-11 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-10-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-16 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-09-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-16 | Truist Securities | Maintains | Buy -> Buy |
| 2024-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-15 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-05-14 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-08 | B of A Securities | Initiate | Buy |
| 2024-04-03 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-04-03 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-04-03 | Truist Securities | Maintains | Buy -> Buy |
| 2024-04-03 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-03-28 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-03-27 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-03-26 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-03-26 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-03-26 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-15 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-09 | Deutsche Bank | Initiate | Buy |